Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA3 | P07451 | 1/20 | 0.36 |
| ▸ | CA4 | P22748 | 1/20 | 0.36 |
| ▸ | CA6 | P23280 | 1/20 | 0.36 |
| ▸ | CA5A | P35218 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | GSK3B | P49841 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.33 |
| ▸ | ACP3 | P15309 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27519474 | 0.95 | TDP1 (0.39) | TDP1CA12CA3CA4CA6 | |
| SCHEMBL8846547 | 0.83 | TDP1 (0.40) | TDP1CA12CA3CA4CA6 | |
| SCHEMBL22392090 | 0.83 | MAPT (0.37) | TDP1ALDH1A1TSHRHSD17B10KDM4E | |
| SCHEMBL29882515 | 0.83 | MAPT (0.37) | TDP1ALDH1A1TSHRHSD17B10KDM4E | |
| SCHEMBL27739229 | 0.83 | KCNH2 (0.39) | TDP1CA12CA3CA4CA6 | |
| SCHEMBL27932138 | 0.80 | CA12 (0.44) | TDP1CA12CA3CA4CA6 | |
| SCHEMBL15659078 | 0.80 | TDP1 (0.38) | TDP1CA12CA3CA4CA6 | |
| SCHEMBL6678949 | 0.79 | ALDH1A1 (0.37) | TDP1ALDH1A1TSHRHSD17B10KDM4E | |
| SCHEMBL10757313 | 0.76 | TDP1 (0.35) | TDP1CA12CA3CA4CA6 | |
| SCHEMBL230856 | 0.76 | TDP1 (0.43) | TDP1CA12CA7CA14ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 208 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200385570-A1 | POLYCARBONATE COMPOSITIONS | BASF SE (DE) | 2020-12-10 | — | — | US | claimed |
| EP-3710145-A1 | POLYCARBONATE COMPOSITIONS | BASF SE (DE) | 2020-09-23 | — | — | EP | claimed |
| CN-111328293-A | Polycarbonate compositions | 巴斯夫欧洲公司 | 2020-06-23 | — | — | CN | claimed |
| US-6476178-B1 | Polycarbonate resin composition | IDEMITSU PETROCHEMICAL CO., LTD. (JP) | 2002-11-05 | — | — | US | claimed |
| US-20260125537-A1 | POLYCARBONATE RESIN COMPOSITION | MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) | 2026-05-07 | — | — | US | disclosed |
| US-12570837-B2 | Polycarbonate resin composition and molded article | IDEMITSU KOSAN CO., LTD. (JP) | 2026-03-10 | — | — | US | disclosed |
| EP-4692233-A1 | POLYCARBONATE RESIN COMPOSITION | Mitsubishi Engineering-Plastics Corporation (JP) | 2026-02-11 | — | — | EP | disclosed |
| EP-3604443-B1 | POLYCARBONATE RESIN COMPOSITION AND MOLDED BODY | IDEMITSU KOSAN CO (JP) | 2025-10-15 | — | — | EP | disclosed |
| US-12398266-B2 | Polycarbonate resin composition | IDEMITSU KOSAN CO., LTD. (JP) | 2025-08-26 | — | — | US | disclosed |
| EP-4596628-A1 | POLYCARBONATE RESIN COMPOSITION | Mitsubishi Engineering-Plastics Corporation (JP) | 2025-08-06 | — | — | EP | disclosed |
| US-20250205637-A1 | GAS SEPARATION MEMBRANE | IDEMITSU KOSAN CO., LTD. (JP) | 2025-06-26 | — | — | US | disclosed |
| EP-4556507-A1 | POLYCARBONATE-POLYORGANOSILOXANE COPOLYMER, POLYCARBONATE RESIN COMPOSITION AND MOLDED BODY | Idemitsu Kosan Co.,Ltd. (JP) | 2025-05-21 | — | — | EP | disclosed |
| US-4670479-A | BLEND INCLUDING RGANIC PHOSPHINE AND PARTIAL ESTER OF MONOBASIC FATTY ACID AND POLYHYDRIC ALCOHOL | TEIJIN CHEMICALS, LTD. (JP) | 1987-06-02 | — | — | US | disclosed |
| EP-0213413-A1 | Polycarbonate resin composition and its use in optical applications | Teijin Chemicals, Ltd. (JP) | 1987-03-11 | — | — | EP | disclosed |
| US-4627949-A | PHOSPHINE STABILIZER | BAYER AKTIENGESELLSCHAFT (DE) | 1986-12-09 | — | — | US | disclosed |
| US-RE32046-E | PHOSPHINES IN OXETANYL-ALKOXYSILANES OR OXETANYL= =METHYL CARBOXYESTERS, HEAT AND OXIDATION RESISTANCE | BAYER AKTIENGESELLSCHAFT (DE) | 1985-12-10 | — | — | US | disclosed |
| EP-0143906-A1 | Process for preparing stabilized polycarbonate moulded articles by vented injection moulding or vented extrusion moulding | BAYER AG (DE) | 1985-06-12 | — | — | EP | disclosed |
| EP-0043998-B1 | STABILIZER MIXTURES, THEIR USE IN STABILIZING THERMOPLASTIC POLYCARBONATES, AND STABILIZED THERMOPLASTIC POLYCARBONATES | BAYER AG (DE) | 1984-04-18 | — | — | EP | disclosed |
| US-4367303-A | Solutions for stabilizing thermoplastic polycarbonates | BAYER AKTIENGESELLSCHAFT (DE) | 1983-01-04 | — | — | US | disclosed |
| EP-0043998-A2 | Stabilizer mixtures, their use in stabilizing thermoplastic polycarbonates, and stabilized thermoplastic polycarbonates | BAYER AG (DE) | 1982-01-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12570837-B2 | Polycarbonate resin composition and molded article | ERCC1, POT1, BMI1 | TDP1 1001/4885CA12 3963/4885CA3 3398/4885 |
| US-20260125537-A1 | POLYCARBONATE RESIN COMPOSITION | COL1A1, RER1, GSTP1 | TDP1 462/4885CA12 2842/4885CA3 806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.